![]() |
![]() |
|
Avalere Analysis Reveals Significant Fluctuations in Medicare Prescription Drug Plan Premiums for 2013 Contact: Erica Garland, 202-745-5119,
egarland@gymr.com Seven of Top 10 PDPs Have Double Digit Increases in Premiums Washington, D.C. – A new analysis by Avalere Health of the Centers for Medicare and Medicaid Services (CMS) Part D Landscape Files shows that seniors in some of the top plans will need to shop around if they want to avoid double digit premium increases in 2013. Humana Walmart's Preferred Rx Plan raised its premium on its popular low-cost plan by 23 percent to $18.50 per month. First Health Part D Premier, First Health Part D Value Plus and Cigna Medicare Rx Plan each raised premiums by more than 15 percent. Overall, seven of the current top 10 prescription drug plans (PDPs) have double digit increases in premiums. But there are alternatives for cost conscious seniors. UnitedHealth's new Medicare Rx Saver Plus PDP is offering premiums averageing just $15 a month, the lowest available in many markets. In past years, low-cost entrants have captured significant market share, and Humana Walmart began the trend with its offering in 2011. Last year, First Health's low-cost offering enrolled 450,000 patients in its first year of operation. Also, Coventry and CVS Caremark have fielded very competitively priced enhanced plans - with premiums below $30 that are likely to attract interest from seniors who are looking for a low premium, but would prefer a more comprehensive benefit plan. Interestingly, these plans are cheaper than the premiums for those sponsors' basic offerings due to their use of preferred pharmacy networks. By employing limited pharmacy networks, plan sponsors are better able to offer such low-cost plans. "Seniors need to carefully assess their options going into this open season to ensure that they have a plan that meets their needs," said Bonnie Washington, senior vice president of Avalere Health. Because of the premium increases, half of the top 10 PDPs will lose eligibility in select regions to retain or receive low-income subsidy (LIS) beneficiaries. The First Health Part D Premier plan will lose LIS eligibility in 10 regions, but Coventry's new basic plan, First Health Essentials, will have LIS eligibility in seven regions. Humana Walmart-Preferred Rx plans will remain LIS eligible in every region. United’s new Saver Plus plan has eligibility in all regions it's offered (30). Other key findings from the Avalere analysis include:
Lost-Cost Premium Plans, 2013*
Source: Avalere Health analysis using DataFrame®, a proprietary database of Medicare Part D plan features and 2013 PDP data released by CMS on September 19, 2012. Monthly Premiums for Top 10 PDPs in 2013
Source: Avalere Health analysis using DataFrame®, a proprietary database of Medicare Part D plan features and 2013 PDP data released by CMS on September 19, 2012. Top 10 PDPs, Number of Regions with $0 Premium Plans, 2012-2013
Source: Avalere Health analysis using DataFrame®, a proprietary database of Medicare Part D plan features and 2013 PDP data released by CMS on September 19, 2012. Avalere Health is an advisory services company whose core purpose is to create innovative solutions to complex healthcare problems. Based in Washington DC, the firm delivers research, analysis, insight, and strategy for leaders in healthcare business and policy. Avalere's experts span 170 staff drawn from the federal government (e.g., CMS, OMB, CBO, and the Congress), Fortune 500 healthcare companies, top consultancies, and nonprofits. The firm offers deep substance in areas ranging from healthcare coverage and financing to the changing role of evidence in healthcare decision-making. Its focus on strategy is supported by a rigorous, in-house analytic research group that uses public and private data to generate quantitative insight. Through events, publications, and interactive programs, Avalere also translates real-time healthcare developments into actionable information. Learn more at www.avalerehealth.net. Return to the News Room.
|
| | Privacy Policy | Terms of Use |